OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor Cell Secretomes in Response to Anti- and Pro-Tumorigenic Agents
Sheng-Zhi Liu, Xun Sun, Kexin Li, et al.
Onco (2021) Vol. 1, Iss. 2, pp. 101-113
Open Access | Times Cited: 7
Sheng-Zhi Liu, Xun Sun, Kexin Li, et al.
Onco (2021) Vol. 1, Iss. 2, pp. 101-113
Open Access | Times Cited: 7
Showing 7 citing articles:
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling
Xun Sun, Kexin Li, Misato Hase, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 929-943
Open Access | Times Cited: 42
Xun Sun, Kexin Li, Misato Hase, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 929-943
Open Access | Times Cited: 42
Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs
Kexin Li, Xun Sun, Rongrong Zha, et al.
Theranostics (2022) Vol. 12, Iss. 7, pp. 3084-3103
Open Access | Times Cited: 18
Kexin Li, Xun Sun, Rongrong Zha, et al.
Theranostics (2022) Vol. 12, Iss. 7, pp. 3084-3103
Open Access | Times Cited: 18
Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis
Kexin Li, Xun Sun, Kazumasa Minami, et al.
Theranostics (2023) Vol. 13, Iss. 4, pp. 1247-1263
Open Access | Times Cited: 10
Kexin Li, Xun Sun, Kazumasa Minami, et al.
Theranostics (2023) Vol. 13, Iss. 4, pp. 1247-1263
Open Access | Times Cited: 10
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
Xun Sun, Kexin Li, Uma K. Aryal, et al.
Molecular Therapy — Oncolytics (2022) Vol. 26, pp. 360-371
Open Access | Times Cited: 15
Xun Sun, Kexin Li, Uma K. Aryal, et al.
Molecular Therapy — Oncolytics (2022) Vol. 26, pp. 360-371
Open Access | Times Cited: 15
Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes
Kexin Li, Xun Sun, Hudie Li, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1641-1656
Open Access | Times Cited: 11
Kexin Li, Xun Sun, Hudie Li, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1641-1656
Open Access | Times Cited: 11
Generation of the Chondroprotective Proteomes by Activating PI3K and TNFα Signaling
Xun Sun, Kexin Li, Marxa L. Figueiredo, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3039-3039
Open Access | Times Cited: 6
Xun Sun, Kexin Li, Marxa L. Figueiredo, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3039-3039
Open Access | Times Cited: 6
Intracellular and extracellular moesins differentially regulate Src activity and β-catenin translocation to the nucleus in breast cancer cells
Sina Ahandoust, Kexin Li, Xun Sun, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 639, pp. 62-69
Closed Access | Times Cited: 2
Sina Ahandoust, Kexin Li, Xun Sun, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 639, pp. 62-69
Closed Access | Times Cited: 2
